Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
EnGeneIC Wins Innovation Award from Australian Financial Review 2019-08-09 12:49
CStone to Build Global R&D Headquarters and Industrialization Base in the Suzhou Industrial Park 2019-08-07 14:47
China Biologic Reports Financial Results for the Second Quarter of 2019 2019-08-06 04:30
New Drug for Diabetes-Induced Vision Loss TGA-Approved for Australian Patients 2019-08-05 20:00
I-Mab Biopharma and TRACON Pharmaceuticals Announce Dosing of the First Patient in a Phase 1 Trial of the CD73 Antibody TJD5 in the U.S. in Patients with Advanced Solid Tumors 2019-08-01 20:06
111 to Announce Second Quarter 2019 Unaudited Financial Results on August 15, 2019 2019-08-01 20:00
Samsung BioLogics and UCB Sign Third Drug Manufacturing Deal 2019-07-31 19:00
GC Pharma Reports Q2 2019 Results 2019-07-30 22:31
Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets 2019-07-29 12:00
China Biologic Products to Report Second Quarter 2019 Financial Results 2019-07-27 04:30
NanoCellect Biomedical Expands Distribution to Australia and New Zealand 2019-07-24 21:57
111 Signs Strategic Cooperation with Harbin Pharmaceutical Group 2019-07-24 20:00
CStone receives approval in China to initiate ivosidenib Phase I bridging registrational study for the treatment of IDH1 mutant relapsed or refractory AML 2019-07-22 12:17
Yuyu Pharma Receives Recognition for Outstanding Company Culture in Korea 2019-07-17 21:00
Yuyu Pharma held the campaign for enhancing corporate transparency 2019-07-11 16:43
MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China 2019-07-11 04:01
CStone announces first patient dosed in China with avapritinib in global Phase III clinical trial in advanced GIST 2019-07-10 10:23
Medeon Led and Completed Investments in Panther Orthopedics and Prodeon 2019-07-08 17:10
CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019 2019-07-02 06:15
I-Mab Announces Dosing of First Patient in a Phase I Clinical Trial of TJC4, a Potentially Differentiated CD47 Antibody, for the Treatment of Cancers in the United States 2019-06-25 22:01
1 121 122 123 124 125 158